Monoclonal Antibodies to Two Glycoproteins of Herpes Simplex Virus Type 2
Overview
Affiliations
Monoclonal antibodies to herpes simplex virus type 2 were found to precipitate different numbers of radiolabeled polypeptides from lysates of virus-infected cells. Antibodies directed against two viral glycoproteins were characterized. Antibodies from hybridoma 17 alpha A2 precipitated a 60,000-molecular-weight polypeptide which chased into a 66,000- and 79,000-molecular-weight polypeptide. All three polypeptides labeled in the presence of [3H]glucosamine and had similar tryptic digest maps. The 60,000-molecular-weight polypeptide also chased into a 31,000-molecular-weight species which did not label with [3H]glucosamine. Antibodies from hybridoma 17 beta C2 precipitated a 50,000-molecular-weight polypeptide which chased into a 56,000- and 80,000-molecular weight polypeptide. These polypeptides also shared a similar tryptic digest map and labeled with [3H]glucosamine. Both monoclonal antibodies were herpes simplex virus type 2 specific. The viral proteins precipitated by 17 alpha A2 antibodies had characteristics similar to those reported for glycoprotein E, whereas the proteins precipitated by 17 beta C2 antibodies appeared to represent a glycoprotein not previously described. This glycoprotein should be tentatively designated glycoprotein F.
Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.
Misra V, Gilchrist J, Weinmaster G, Qualtiere L, van den Hurk S, Babiuk L J Virol. 1982; 43(3):1046-54.
PMID: 7143563 PMC: 256216. DOI: 10.1128/JVI.43.3.1046-1054.1982.
The application of monoclonal antibodies in the study of viruses.
Carter M, Ter Meulen V Adv Virus Res. 1984; 29:95-130.
PMID: 6397053 PMC: 7131468. DOI: 10.1016/s0065-3527(08)60406-6.
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.
Marsden H, Buckmaster A, Palfreyman J, Hope R, Minson A J Virol. 1984; 50(2):547-54.
PMID: 6323754 PMC: 255668. DOI: 10.1128/JVI.50.2.547-554.1984.
Ashley R, Corey L J Clin Invest. 1984; 73(3):681-8.
PMID: 6323525 PMC: 425069. DOI: 10.1172/JCI111260.
Zezulak K, Spear P J Virol. 1984; 50(1):258-62.
PMID: 6321794 PMC: 255607. DOI: 10.1128/JVI.50.1.258-262.1984.